COVID-19 Outbreak-Global Opioid-Induced Constipation Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

Table of Content

1 Opioid-Induced Constipation Introduction and Market Overview

• 1.1 Objectives of the Study
• 1.2 Overview of Opioid-Induced Constipation
• 1.3 Scope of The Study
  • 1.3.1 Key Market Segments
  • 1.3.2 Players Covered
  • 1.3.3 COVID-19's impact on the Opioid-Induced Constipation industry
• 1.4 Methodology of The Study
• 1.5 Research Data Source

2 Executive Summary

• 2.1 Market Overview
  • 2.1.1 Global Opioid-Induced Constipation Market Size, 2015 – 2020
  • 2.1.2 Global Opioid-Induced Constipation Market Size by Type, 2015 – 2020
  • 2.1.3 Global Opioid-Induced Constipation Market Size by Application, 2015 – 2020
  • 2.1.4 Global Opioid-Induced Constipation Market Size by Region, 2015 - 2025
• 2.2 Business Environment Analysis
  • 2.2.1 Global COVID-19 Status and Economic Overview
  • 2.2.2 Influence of COVID-19 Outbreak on Opioid-Induced Constipation Industry Development

3 Industry Chain Analysis

• 3.1 Upstream Raw Material Suppliers of Opioid-Induced Constipation Analysis
• 3.2 Major Players of Opioid-Induced Constipation
• 3.3 Opioid-Induced Constipation Manufacturing Cost Structure Analysis
  • 3.3.1 Production Process Analysis
  • 3.3.2 Manufacturing Cost Structure of Opioid-Induced Constipation
  • 3.3.3 Labor Cost of Opioid-Induced Constipation
• 3.4 Market Distributors of Opioid-Induced Constipation
• 3.5 Major Downstream Buyers of Opioid-Induced Constipation Analysis
• 3.6 The Impact of Covid-19 From the Perspective of Industry Chain
• 3.7 Regional Import and Export Controls Will Exist for a Long Time
• 3.8 Continued downward PMI Spreads Globally

4 Global Opioid-Induced Constipation Market, by Type

• 4.1 Global Opioid-Induced Constipation Value and Market Share by Type (2015-2020)
• 4.2 Global Opioid-Induced Constipation Production and Market Share by Type (2015-2020)
• 4.3 Global Opioid-Induced Constipation Value and Growth Rate by Type (2015-2020)
  • 4.3.1 Global Opioid-Induced Constipation Value and Growth Rate of Oral
  • 4.3.2 Global Opioid-Induced Constipation Value and Growth Rate of Parenteral
• 4.4 Global Opioid-Induced Constipation Price Analysis by Type (2015-2020)

5 Opioid-Induced Constipation Market, by Application

• 5.1 Downstream Market Overview
• 5.2 Global Opioid-Induced Constipation Consumption and Market Share by Application (2015-2020)
• 5.3 Global Opioid-Induced Constipation Consumption and Growth Rate by Application (2015-2020)
  • 5.3.1 Global Opioid-Induced Constipation Consumption and Growth Rate of Drugstore (2015-2020)
  • 5.3.2 Global Opioid-Induced Constipation Consumption and Growth Rate of Hospital (2015-2020)
  • 5.3.3 Global Opioid-Induced Constipation Consumption and Growth Rate of Others (2015-2020)

6 Global Opioid-Induced Constipation Market Analysis by Regions

• 6.1 Global Opioid-Induced Constipation Sales, Revenue and Market Share by Regions
  • 6.1.1 Global Opioid-Induced Constipation Sales by Regions (2015-2020)
  • 6.1.2 Global Opioid-Induced Constipation Revenue by Regions (2015-2020)
• 6.2 North America Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 6.3 Europe Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 6.4 Asia-Pacific Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 6.5 Middle East and Africa Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 6.6 South America Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

7 North America Opioid-Induced Constipation Market Analysis by Countries

• 7.1 The Influence of COVID-19 on North America Market
• 7.2 North America Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
  • 7.2.1 North America Opioid-Induced Constipation Sales by Countries (2015-2020)
  • 7.2.2 North America Opioid-Induced Constipation Revenue by Countries (2015-2020)
• 7.3 United States Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 7.4 Canada Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 7.5 Mexico Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

8 Europe Opioid-Induced Constipation Market Analysis by Countries

• 8.1 The Influence of COVID-19 on Europe Market
• 8.2 Europe Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
  • 8.2.1 Europe Opioid-Induced Constipation Sales by Countries (2015-2020)
  • 8.2.2 Europe Opioid-Induced Constipation Revenue by Countries (2015-2020)
• 8.3 Germany Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 8.4 UK Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 8.5 France Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 8.6 Italy Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 8.7 Spain Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 8.8 Russia Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

9 Asia Pacific Opioid-Induced Constipation Market Analysis by Countries

• 9.1 The Influence of COVID-19 on Asia Pacific Market
• 9.2 Asia Pacific Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
  • 9.2.1 Asia Pacific Opioid-Induced Constipation Sales by Countries (2015-2020)
  • 9.2.2 Asia Pacific Opioid-Induced Constipation Revenue by Countries (2015-2020)
• 9.3 China Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 9.4 Japan Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 9.5 South Korea Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 9.6 India Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 9.7 Southeast Asia Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 9.8 Australia Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

10 Middle East and Africa Opioid-Induced Constipation Market Analysis by Countries

• 10.1 The Influence of COVID-19 on Middle East and Africa Market
• 10.2 Middle East and Africa Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
  • 10.2.1 Middle East and Africa Opioid-Induced Constipation Sales by Countries (2015-2020)
  • 10.2.2 Middle East and Africa Opioid-Induced Constipation Revenue by Countries (2015-2020)
• 10.3 Saudi Arabia Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 10.4 UAE Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 10.5 Egypt Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 10.6 Nigeria Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 10.7 South Africa Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

11 South America Opioid-Induced Constipation Market Analysis by Countries

• 11.1 The Influence of COVID-19 on Middle East and Africa Market
• 11.2 South America Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
  • 11.2.1 South America Opioid-Induced Constipation Sales by Countries (2015-2020)
  • 11.2.2 South America Opioid-Induced Constipation Revenue by Countries (2015-2020)
• 11.3 Brazil Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 11.4 Argentina Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 11.5 Columbia Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 11.6 Chile Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

12 Competitive Landscape

• 12.1 GlaxoSmithKline
  • 12.1.1 GlaxoSmithKline Basic Information
  • 12.1.2 Opioid-Induced Constipation Product Introduction
  • 12.1.3 GlaxoSmithKline Production, Value, Price, Gross Margin 2015-2020
• 12.2 Abbott
  • 12.2.1 Abbott Basic Information
  • 12.2.2 Opioid-Induced Constipation Product Introduction
  • 12.2.3 Abbott Production, Value, Price, Gross Margin 2015-2020
• 12.3 Bayer
  • 12.3.1 Bayer Basic Information
  • 12.3.2 Opioid-Induced Constipation Product Introduction
  • 12.3.3 Bayer Production, Value, Price, Gross Margin 2015-2020
• 12.4 Nektar Therapeutics
  • 12.4.1 Nektar Therapeutics Basic Information
  • 12.4.2 Opioid-Induced Constipation Product Introduction
  • 12.4.3 Nektar Therapeutics Production, Value, Price, Gross Margin 2015-2020
• 12.5 Mundipharma
  • 12.5.1 Mundipharma Basic Information
  • 12.5.2 Opioid-Induced Constipation Product Introduction
  • 12.5.3 Mundipharma Production, Value, Price, Gross Margin 2015-2020
• 12.6 Progenics Pharmaceuticals
  • 12.6.1 Progenics Pharmaceuticals Basic Information
  • 12.6.2 Opioid-Induced Constipation Product Introduction
  • 12.6.3 Progenics Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
• 12.7 Ironwood Pharmaceuticals
  • 12.7.1 Ironwood Pharmaceuticals Basic Information
  • 12.7.2 Opioid-Induced Constipation Product Introduction
  • 12.7.3 Ironwood Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
• 12.8 Synergy Pharmaceuticals
  • 12.8.1 Synergy Pharmaceuticals Basic Information
  • 12.8.2 Opioid-Induced Constipation Product Introduction
  • 12.8.3 Synergy Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
• 12.9 Boehringer Ingelheim
  • 12.9.1 Boehringer Ingelheim Basic Information
  • 12.9.2 Opioid-Induced Constipation Product Introduction
  • 12.9.3 Boehringer Ingelheim Production, Value, Price, Gross Margin 2015-2020
• 12.10 Johnson and Johnson
  • 12.10.1 Johnson and Johnson Basic Information
  • 12.10.2 Opioid-Induced Constipation Product Introduction
  • 12.10.3 Johnson and Johnson Production, Value, Price, Gross Margin 2015-2020
• 12.11 Valeant Pharmaceuticals International
  • 12.11.1 Valeant Pharmaceuticals International Basic Information
  • 12.11.2 Opioid-Induced Constipation Product Introduction
  • 12.11.3 Valeant Pharmaceuticals International Production, Value, Price, Gross Margin 2015-2020
• 12.12 Daiichi Sankyo
  • 12.12.1 Daiichi Sankyo Basic Information
  • 12.12.2 Opioid-Induced Constipation Product Introduction
  • 12.12.3 Daiichi Sankyo Production, Value, Price, Gross Margin 2015-2020
• 12.13 Daewoong
  • 12.13.1 Daewoong Basic Information
  • 12.13.2 Opioid-Induced Constipation Product Introduction
  • 12.13.3 Daewoong Production, Value, Price, Gross Margin 2015-2020
• 12.14 Shionogi
  • 12.14.1 Shionogi Basic Information
  • 12.14.2 Opioid-Induced Constipation Product Introduction
  • 12.14.3 Shionogi Production, Value, Price, Gross Margin 2015-2020
• 12.15 Theravance
  • 12.15.1 Theravance Basic Information
  • 12.15.2 Opioid-Induced Constipation Product Introduction
  • 12.15.3 Theravance Production, Value, Price, Gross Margin 2015-2020
• 12.16 Takeda Pharmaceutical
  • 12.16.1 Takeda Pharmaceutical Basic Information
  • 12.16.2 Opioid-Induced Constipation Product Introduction
  • 12.16.3 Takeda Pharmaceutical Production, Value, Price, Gross Margin 2015-2020
• 12.17 SLA Pharma
  • 12.17.1 SLA Pharma Basic Information
  • 12.17.2 Opioid-Induced Constipation Product Introduction
  • 12.17.3 SLA Pharma Production, Value, Price, Gross Margin 2015-2020
• 12.18 Pfizer
  • 12.18.1 Pfizer Basic Information
  • 12.18.2 Opioid-Induced Constipation Product Introduction
  • 12.18.3 Pfizer Production, Value, Price, Gross Margin 2015-2020
• 12.19 Merck
  • 12.19.1 Merck Basic Information
  • 12.19.2 Opioid-Induced Constipation Product Introduction
  • 12.19.3 Merck Production, Value, Price, Gross Margin 2015-2020
• 12.20 C.B. Fleet
  • 12.20.1 C.B. Fleet Basic Information
  • 12.20.2 Opioid-Induced Constipation Product Introduction
  • 12.20.3 C.B. Fleet Production, Value, Price, Gross Margin 2015-2020
• 12.21 AstraZeneca
  • 12.21.1 AstraZeneca Basic Information
  • 12.21.2 Opioid-Induced Constipation Product Introduction
  • 12.21.3 AstraZeneca Production, Value, Price, Gross Margin 2015-2020
• 12.22 Cosmo Pharmaceuticals
  • 12.22.1 Cosmo Pharmaceuticals Basic Information
  • 12.22.2 Opioid-Induced Constipation Product Introduction
  • 12.22.3 Cosmo Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
• 12.23 Sucampo
  • 12.23.1 Sucampo Basic Information
  • 12.23.2 Opioid-Induced Constipation Product Introduction
  • 12.23.3 Sucampo Production, Value, Price, Gross Margin 2015-2020

13 Industry Outlook

• 13.1 Market Driver Analysis
  • 13.1.2 Market Restraints Analysis
  • 13.1.3 Market Trends Analysis
• 13.2 Merger, Acquisition and New Investment
• 13.3 News of Product Release

14 Global Opioid-Induced Constipation Market Forecast

• 14.1 Global Opioid-Induced Constipation Market Value & Volume Forecast, by Type (2020-2025)
  • 14.1.1 Oral Market Value and Volume Forecast (2020-2025)
  • 14.1.2 Parenteral Market Value and Volume Forecast (2020-2025)
• 14.2 Global Opioid-Induced Constipation Market Value & Volume Forecast, by Application (2020-2025)
  • 14.2.1 Drugstore Market Value and Volume Forecast (2020-2025)
  • 14.2.2 Hospital Market Value and Volume Forecast (2020-2025)
  • 14.2.3 Others Market Value and Volume Forecast (2020-2025)
• 14.3 Opioid-Induced Constipation Market Analysis and Forecast by Region
  • 14.3.1 North America Market Value and Consumption Forecast (2020-2025)
  • 14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
  • 14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
  • 14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
  • 14.3.5 South America Market Value and Consumption Forecast (2020-2025)

15 New Project Feasibility Analysis

• 15.1 Industry Barriers and New Entrants SWOT Analysis
  • 15.1.1 Porter’s Five Forces Analysis
  • 15.1.2 New Entrants SWOT Analysis
• 15.2 Analysis and Suggestions on New Project Investment

List of Tables and Figures

Figure Product Picture of Opioid-Induced Constipation

Table Product Specification of Opioid-Induced Constipation

Table Opioid-Induced Constipation Key Market Segments

Table Key Players Opioid-Induced Constipation Covered

Figure Global Opioid-Induced Constipation Market Size, 2015 – 2025

Table Different Types of Opioid-Induced Constipation

Figure Global Opioid-Induced Constipation Value ($) Segment by Type from 2015-2020

Figure Global Opioid-Induced Constipation Market Share by Types in 2019

Table Different Applications of Opioid-Induced Constipation

Figure Global Opioid-Induced Constipation Value ($) Segment by Applications from 2015-2020

Figure Global Opioid-Induced Constipation Market Share by Applications in 2019

Figure Global Opioid-Induced Constipation Market Share by Regions in 2019

Figure North America Opioid-Induced Constipation Production Value ($) and Growth Rate (2015-2020)

Figure Europe Opioid-Induced Constipation Production Value ($) and Growth Rate (2015-2020)

Figure Asia Pacific Opioid-Induced Constipation Production Value ($) and Growth Rate (2015-2020)

Figure Middle East and Africa Opioid-Induced Constipation Production Value ($) and Growth Rate (2015-2020)

Figure South America Opioid-Induced Constipation Production Value ($) and Growth Rate (2015-2020)

Table Global COVID-19 Status and Economic Overview

Figure Global COVID-19 Status

Figure COVID-19 Comparison of Major Countries

Figure Industry Chain Analysis of Opioid-Induced Constipation

Table Upstream Raw Material Suppliers of Opioid-Induced Constipation with Contact Information

Table Major Players Headquarters, and Service Area of Opioid-Induced Constipation

Figure Major Players Production Value Market Share of Opioid-Induced Constipation in 2019

Table Major Players Opioid-Induced Constipation Product Types in 2019

Figure Production Process of Opioid-Induced Constipation

Figure Manufacturing Cost Structure of Opioid-Induced Constipation

Figure Channel Status of Opioid-Induced Constipation

Table Major Distributors of Opioid-Induced Constipation with Contact Information

Table Major Downstream Buyers of Opioid-Induced Constipation with Contact Information

Table Global Opioid-Induced Constipation Value ($) by Type (2015-2020)

Table Global Opioid-Induced Constipation Value Share by Type (2015-2020)

Figure Global Opioid-Induced Constipation Value Share by Type (2015-2020)

Table Global Opioid-Induced Constipation Production by Type (2015-2020)

Table Global Opioid-Induced Constipation Production Share by Type (2015-2020)

Figure Global Opioid-Induced Constipation Production Share by Type (2015-2020)

Figure Global Opioid-Induced Constipation Value ($) and Growth Rate of Oral (2015-2020)

Figure Global Opioid-Induced Constipation Value ($) and Growth Rate of Parenteral (2015-2020)

Figure Global Opioid-Induced Constipation Price by Type (2015-2020)

Figure Downstream Market Overview

Table Global Opioid-Induced Constipation Consumption by Application (2015-2020)

Table Global Opioid-Induced Constipation Consumption Market Share by Application (2015-2020)

Figure Global Opioid-Induced Constipation Consumption Market Share by Application (2015-2020)

Figure Global Opioid-Induced Constipation Consumption and Growth Rate of Drugstore (2015-2020)

Figure Global Opioid-Induced Constipation Consumption and Growth Rate of Hospital (2015-2020)

Figure Global Opioid-Induced Constipation Consumption and Growth Rate of Others (2015-2020)

Figure Global Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure Global Opioid-Induced Constipation Revenue (M USD) and Growth (2015-2020)

Table Global Opioid-Induced Constipation Sales by Regions (2015-2020)

Table Global Opioid-Induced Constipation Sales Market Share by Regions (2015-2020)

Table Global Opioid-Induced Constipation Revenue (M USD) by Regions (2015-2020)

Table Global Opioid-Induced Constipation Revenue Market Share by Regions (2015-2020)

Table Global Opioid-Induced Constipation Revenue Market Share by Regions in 2015

Table Global Opioid-Induced Constipation Revenue Market Share by Regions in 2019

Figure North America Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure Europe Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure South America Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure North America COVID-19 Status

Figure North America COVID-19 Confirmed Cases Major Distribution

Figure North America Opioid-Induced Constipation Revenue (M USD) and Growth (2015-2020)

Table North America Opioid-Induced Constipation Sales by Countries (2015-2020)

Table North America Opioid-Induced Constipation Sales Market Share by Countries (2015-2020)

Table North America Opioid-Induced Constipation Revenue (M USD) by Countries (2015-2020)

Table North America Opioid-Induced Constipation Revenue Market Share by Countries (2015-2020)

Figure United States Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure Canada Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure Mexico Opioid-Induced Constipation Sales and Growth (2015-2020)

Figure Europe COVID-19 Status

Figure Europe COVID-19 Confirmed Cases Major Distribution

Figure Europe Opioid-Induced Constipation Revenue (M USD) and Growth (2015-2020)

Table Europe Opioid-Induced Constipation Sales by Countries (2015-2020)

Table Europe Opioid-Induced Constipation Sales Market Share by Countries (2015-2020)

Table Europe Opioid-Induced Constipation Revenue (M USD) by Countries (2015-2020)

Table Europe Opioid-Induced Constipation Revenue Market Share by Countries (2015-2020)

Figure Germany Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure UK Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure France Opioid-Induced Constipation Sales and Growth (2015-2020)

Figure Italy Opioid-Induced Constipation Sales and Growth (2015-2020)

Figure Spain Opioid-Induced Constipation Sales and Growth (2015-2020)

Figure Russia Opioid-Induced Constipation Sales and Growth (2015-2020)

Figure Asia Pacific COVID-19 Status

Figure Asia Pacific Opioid-Induced Constipation Revenue (M USD) and Growth (2015-2020)

Table Asia Pacific Opioid-Induced Constipation Sales by Countries (2015-2020)

Table Asia Pacific Opioid-Induced Constipation Sales Market Share by Countries (2015-2020)

Table Asia Pacific Opioid-Induced Constipation Revenue (M USD) by Countries (2015-2020)

Table Asia Pacific Opioid-Induced Constipation Revenue Market Share by Countries (2015-2020)

Figure China Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure Japan Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure South Korea Opioid-Induced Constipation Sales and Growth (2015-2020)

Figure India Opioid-Induced Constipation Sales and Growth (2015-2020)

Figure Southeast Asia Opioid-Induced Constipation Sales and Growth (2015-2020)

Figure Australia Opioid-Induced Constipation Sales and Growth (2015-2020)

Figure Middle East Opioid-Induced Constipation Revenue (M USD) and Growth (2015-2020)

Table Middle East Opioid-Induced Constipation Sales by Countries (2015-2020)

Table Middle East and Africa Opioid-Induced Constipation Sales Market Share by Countries (2015-2020)

Table Middle East and Africa Opioid-Induced Constipation Revenue (M USD) by Countries (2015-2020)

Table Middle East and Africa Opioid-Induced Constipation Revenue Market Share by Countries (2015-2020)

Figure Saudi Arabia Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure UAE Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure Egypt Opioid-Induced Constipation Sales and Growth (2015-2020)

Figure Nigeria Opioid-Induced Constipation Sales and Growth (2015-2020)

Figure South Africa Opioid-Induced Constipation Sales and Growth (2015-2020)

Figure South America Opioid-Induced Constipation Revenue (M USD) and Growth (2015-2020)

Table South America Opioid-Induced Constipation Sales by Countries (2015-2020)

Table South America Opioid-Induced Constipation Sales Market Share by Countries (2015-2020)

Table South America Opioid-Induced Constipation Revenue (M USD) by Countries (2015-2020)

Table South America Opioid-Induced Constipation Revenue Market Share by Countries (2015-2020)

Figure Brazil Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure Argentina Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure Columbia Opioid-Induced Constipation Sales and Growth (2015-2020)

Figure Chile Opioid-Induced Constipation Sales and Growth (2015-2020)

Figure Top 3 Market Share of Opioid-Induced Constipation Companies in 2019

Figure Top 6 Market Share of Opioid-Induced Constipation Companies in 2019

Table Major Players Production Value ($) Share (2015-2020)

Table GlaxoSmithKline Profile

Table GlaxoSmithKline Product Introduction

Figure GlaxoSmithKline Production and Growth Rate

Figure GlaxoSmithKline Value ($) Market Share 2015-2020

Table Abbott Profile

Table Abbott Product Introduction

Figure Abbott Production and Growth Rate

Figure Abbott Value ($) Market Share 2015-2020

Table Bayer Profile

Table Bayer Product Introduction

Figure Bayer Production and Growth Rate

Figure Bayer Value ($) Market Share 2015-2020

Table Nektar Therapeutics Profile

Table Nektar Therapeutics Product Introduction

Figure Nektar Therapeutics Production and Growth Rate

Figure Nektar Therapeutics Value ($) Market Share 2015-2020

Table Mundipharma Profile

Table Mundipharma Product Introduction

Figure Mundipharma Production and Growth Rate

Figure Mundipharma Value ($) Market Share 2015-2020

Table Progenics Pharmaceuticals Profile

Table Progenics Pharmaceuticals Product Introduction

Figure Progenics Pharmaceuticals Production and Growth Rate

Figure Progenics Pharmaceuticals Value ($) Market Share 2015-2020

Table Ironwood Pharmaceuticals Profile

Table Ironwood Pharmaceuticals Product Introduction

Figure Ironwood Pharmaceuticals Production and Growth Rate

Figure Ironwood Pharmaceuticals Value ($) Market Share 2015-2020

Table Synergy Pharmaceuticals Profile

Table Synergy Pharmaceuticals Product Introduction

Figure Synergy Pharmaceuticals Production and Growth Rate

Figure Synergy Pharmaceuticals Value ($) Market Share 2015-2020

Table Boehringer Ingelheim Profile

Table Boehringer Ingelheim Product Introduction

Figure Boehringer Ingelheim Production and Growth Rate

Figure Boehringer Ingelheim Value ($) Market Share 2015-2020

Table Johnson and Johnson Profile

Table Johnson and Johnson Product Introduction

Figure Johnson and Johnson Production and Growth Rate

Figure Johnson and Johnson Value ($) Market Share 2015-2020

Table Valeant Pharmaceuticals International Profile

Table Valeant Pharmaceuticals International Product Introduction

Figure Valeant Pharmaceuticals International Production and Growth Rate

Figure Valeant Pharmaceuticals International Value ($) Market Share 2015-2020

Table Daiichi Sankyo Profile

Table Daiichi Sankyo Product Introduction

Figure Daiichi Sankyo Production and Growth Rate

Figure Daiichi Sankyo Value ($) Market Share 2015-2020

Table Daewoong Profile

Table Daewoong Product Introduction

Figure Daewoong Production and Growth Rate

Figure Daewoong Value ($) Market Share 2015-2020

Table Shionogi Profile

Table Shionogi Product Introduction

Figure Shionogi Production and Growth Rate

Figure Shionogi Value ($) Market Share 2015-2020

Table Theravance Profile

Table Theravance Product Introduction

Figure Theravance Production and Growth Rate

Figure Theravance Value ($) Market Share 2015-2020

Table Takeda Pharmaceutical Profile

Table Takeda Pharmaceutical Product Introduction

Figure Takeda Pharmaceutical Production and Growth Rate

Figure Takeda Pharmaceutical Value ($) Market Share 2015-2020

Table SLA Pharma Profile

Table SLA Pharma Product Introduction

Figure SLA Pharma Production and Growth Rate

Figure SLA Pharma Value ($) Market Share 2015-2020

Table Pfizer Profile

Table Pfizer Product Introduction

Figure Pfizer Production and Growth Rate

Figure Pfizer Value ($) Market Share 2015-2020

Table Merck Profile

Table Merck Product Introduction

Figure Merck Production and Growth Rate

Figure Merck Value ($) Market Share 2015-2020

Table C.B. Fleet Profile

Table C.B. Fleet Product Introduction

Figure C.B. Fleet Production and Growth Rate

Figure C.B. Fleet Value ($) Market Share 2015-2020

Table AstraZeneca Profile

Table AstraZeneca Product Introduction

Figure AstraZeneca Production and Growth Rate

Figure AstraZeneca Value ($) Market Share 2015-2020

Table Cosmo Pharmaceuticals Profile

Table Cosmo Pharmaceuticals Product Introduction

Figure Cosmo Pharmaceuticals Production and Growth Rate

Figure Cosmo Pharmaceuticals Value ($) Market Share 2015-2020

Table Sucampo Profile

Table Sucampo Product Introduction

Figure Sucampo Production and Growth Rate

Figure Sucampo Value ($) Market Share 2015-2020

Table Market Driving Factors of Opioid-Induced Constipation

Table Merger, Acquisition and New Investment

Table Global Opioid-Induced Constipation Market Value ($) Forecast, by Type

Table Global Opioid-Induced Constipation Market Volume Forecast, by Type

Figure Global Opioid-Induced Constipation Market Value ($) and Growth Rate Forecast of Oral (2020-2025)

Figure Global Opioid-Induced Constipation Market Volume ($) and Growth Rate Forecast of Oral (2020-2025)

Figure Global Opioid-Induced Constipation Market Value ($) and Growth Rate Forecast of Parenteral (2020-2025)

Figure Global Opioid-Induced Constipation Market Volume ($) and Growth Rate Forecast of Parenteral (2020-2025)

Table Global Market Value ($) Forecast by Application (2020-2025)

Table Global Market Volume Forecast by Application (2020-2025)

Figure Market Value ($) and Growth Rate Forecast of Drugstore (2020-2025)

Figure Market Volume and Growth Rate Forecast of Drugstore (2020-2025)

Figure Market Value ($) and Growth Rate Forecast of Hospital (2020-2025)

Figure Market Volume and Growth Rate Forecast of Hospital (2020-2025)

Figure Market Value ($) and Growth Rate Forecast of Others (2020-2025)

Figure Market Volume and Growth Rate Forecast of Others (2020-2025)

Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)

Figure North America Consumption and Growth Rate Forecast (2020-2025)

Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)

Figure Europe Consumption and Growth Rate Forecast (2020-2025)

Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)

Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)

Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)

Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)

Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)

Figure South America Consumption and Growth Rate Forecast (2020-2025)

Figure Porter’s Five Forces Analysis

Table New Entrants SWOT Analysis

Table New Project Analysis of Investment Recovery